| 000 | 01655 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516170813.0 | ||
| 264 | 0 | _c20140813 | |
| 008 | 201408s 0 0 eng d | ||
| 022 | _a1525-0024 | ||
| 024 | 7 |
_a10.1038/mt.2013.217 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoreno-Montañés, Javier | |
| 245 | 0 | 0 |
_aPhase I clinical trial of SYL040012, a small interfering RNA targeting β-adrenergic receptor 2, for lowering intraocular pressure. _h[electronic resource] |
| 260 |
_bMolecular therapy : the journal of the American Society of Gene Therapy _cJan 2014 |
||
| 300 |
_a226-32 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntraocular Pressure _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOphthalmic Solutions _xadministration & dosage |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xadministration & dosage |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, beta-2 _xgenetics |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aSádaba, Belén | |
| 700 | 1 | _aRuz, Verónica | |
| 700 | 1 | _aGómez-Guiu, Almudena | |
| 700 | 1 | _aZarranz, Javier | |
| 700 | 1 | _aGonzález, María Victoria | |
| 700 | 1 | _aPañeda, Covadonga | |
| 700 | 1 | _aJimenez, Ana Isabel | |
| 773 | 0 |
_tMolecular therapy : the journal of the American Society of Gene Therapy _gvol. 22 _gno. 1 _gp. 226-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/mt.2013.217 _zAvailable from publisher's website |
| 999 |
_c23078400 _d23078400 |
||